BIOTE REPORTS COMPLICATION RATES UNDER 1% IN STUDY EVALUATING THERAPY COMPLICATIONS AND CONTINUATION IRVING, Texas–( BUSINESS WIRE )–Delivering testosterone via bioabsorbable pellets inserted under the skin is a low-risk approach to long-term hormone therapy for women and men, according to

Real World Data of 2,337 Patients Over Nine Years Is Second Long-Term Study Showing Such Benefits IRVING, Texas--( BUSINESS WIRE )--Women who took testosterone via hormone pellets as part of bioidentical hormone replacement therapy (BHRT) had a 35.5% lower incidence of invasive breast cancer